Page
%P
-
Article
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas
Psoriasis, a chronic inflammatory condition, often presents challenges in treatment, particularly in areas such as nails, palms/soles, scalp/face, and genitalia. Monoclonal antibodies (mAb) like risankizumab t...